GlassScriptPhysician profile
Mihae Kim
NPI 1750714408
$1,507.50
in general payments reported to CMS, 2019-2025
18 companies · $461 in 2025
The $461 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $575 · 2022: $181 · 2023: $166 · 2024: $124 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $751.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $184.11 | 2022-2025 | Kisunla, Amyvid |
| Acadia Pharmaceuticals INC | $182.91 | 2025 | Nuplazid |
| Abbvie INC. | $180.31 | 2021-2025 | |
| Boston Scientific Corporation | $148.13 | 2023 | Wavewriter Alpha Prime 16 |
| Alkermes, INC. | $125.00 | 2021 | |
| Genentech USA, INC. | $106.64 | 2021 | |
| Biogen, INC. | $101.43 | 2021-2025 | Leqembi |
| Alexion Pharmaceuticals, INC. | $99.06 | 2021-2025 | Ultomiris |
| Amneal Pharmaceuticals LLC | $69.96 | 2021-2025 | Crexont |
| Merz Pharmaceuticals, LLC | $51.24 | 2021-2025 | Inbrija |
| Catalyst Pharmaceuticals, INC. | $50.59 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.64 | 2022 | |
| Argenx US, INC. | $40.14 | 2022-2025 | Vyvgart Hytrulo |
| Csl Behring | $31.76 | 2022-2023 | Hizentra |
| Abbott Laboratories | $28.55 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $24.73 | 2025 | |
| Mdd US Operations, LLC | $24.62 | 2024 | Gocovri |
| Xeris Pharmaceuticals, INC. | $16.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mihae Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.